Low-dose XXXX effectively prevents @entity1209 after ambulatory laparoscopic surgery.

@entity1 @entity619 @entity1769 @entity1209
PURPOSE: To evaluate the prophylactic effect of low-dose @entity619 (5 mg) on @entity1209 ( @entity1209 ) in @entity1 undergoing ambulatory laparoscopic surgery. @entity1769 and saline served as controls. METHODS: One hundred twenty @entity1 (n=40 in each of the three groups) undergoing ambulatory laparoscopic tubal ligation under general anesthesia were enrolled in this randomized, double-blinded, placebo-controlled study. After tracheal intubation, group I received i.v. @entity619 5 mg, whereas groups II and III received i.v. @entity1769 10 mg and saline, respectively. RESULTS: @entity1 in group I reported a lower incidence of @entity1209 and requested less rescue antiemetics than those in group III during the first four postoperative hours (P <0.01). @entity1 in group I reported a lower incidence of @entity1209 than those in groups II (P <0.05) and III (P <0.01) during the 24-hr postoperative period. Groups II and III did not differ from each other in the incidence of @entity1209 and the proportion of @entity1 who requested rescue antiemetics. CONCLUSION: Prophylactic iv @entity619 5 mg significantly reduces the incidence of @entity1209 in @entity1 undergoing ambulatory laparoscopic tubal ligation. At this dose, @entity619 is more effective than @entity1769 10 mg or placebo.
